• Mutation; HGNC; HGNC:1100; BRCA1; Simple; p.Glu914Lys (c.2740G>A); ClinVar=VCV000479250; Zygosity=Unspecified (PubMed=28273451).
  
• Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala305Gly; Zygosity=Unspecified (PubMed=28273451).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro223Leu (c.668C>T); ClinVar=VCV000234214; Zygosity=Unspecified (PubMed=28273451).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Val274Phe (c.820G>T); ClinVar=VCV000376674; Zygosity=Unspecified (PubMed=28273451).
  

PubMed=10381137; DOI=10.1016/S0304-3835(98)00270-5
Ohta H., Sakamoto H., Satoh K.
In vitro effects of gonadotropin-releasing hormone (GnRH) analogue on cancer cell sensitivity to cis-platinum.
Cancer Lett. 134:111-118(1998)

PubMed=18720132; DOI=10.1080/10717540802329183
Serikawa T., Kikuchi H., Oite T., Tanaka K.
Enhancement of gene expression efficiency using cationic liposomes on ovarian cancer cells.
Drug Deliv. 15:523-529(2008)

PubMed=28273451; DOI=10.1016/j.celrep.2017.02.028
Medrano M., Communal L., Brown K.R., Iwanicki M., Normand J., Paterson J., Sircoulomb F., Krzyzanowski P.M., Novak M., Doodnauth S.A., Suarez Saiz F.J., Cullis J., Al-awar R., Neel B.G., McPherson J., Drapkin R.I., Ailles L., Mes-Masson A.-M., Rottapel R.
Interrogation of functional cell-surface markers identifies CD151 dependency in high-grade serous ovarian cancer.
Cell Rep. 18:2343-2358(2017)